NSRGF (NSRGF) Stock Price & Analysis
NSRGF (NSRGF) rose 2.58% to USD 99.5 as of July 25, 2026 at 03:03 UTC, according to Nexqual real-time market data.
NSRGF last closed at USD 97; the session ranged USD 99.25–99.5 on volume of 850 shares. Market capitalization is $255.94B, with a 52-week range of USD 85–109.37 (OID). Source: Nexqual, July 25, 2026 at 03:03 UTC.
Key Statistics (as of July 25, 2026 at 03:03 UTC)
| Price | USD 99.5 |
|---|---|
| Change | ▲ 2.58% (up) |
| Previous Close | USD 97 |
| Open | USD 99.25 |
| Day Range | USD 99.25 – 99.5 |
| 52-Week Range | USD 85 – 109.37 |
| Volume | 850 shares |
| Market Cap | $255.94B |
| Exchange | OID |
Technical Analysis (NSRGF)
Nexqual's technical model rates NSRGF "SELL" based on 1 bullish and 4 bearish signals across 125 daily candles, as of July 25, 2026 at 03:03 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 46.21 (neutral) |
| vs SMA50 | Below (USD 100.42) |
| MACD | 0.38 (positive) |
Analyst Ratings (NSRGF)
Wall Street analysts rate NSRGF "None", per Nexqual as of July 25, 2026 at 03:03 UTC.
| Consensus Rating | None |
|---|
Earnings (NSRGF)
| Revenue Estimate | $22.66B |
|---|
Source: Nexqual, July 25, 2026 at 03:03 UTC.
Financials & Fundamentals (NSRGF)
| Total Revenue | $88.78B |
|---|---|
| Revenue Growth (YoY) | -2.50% |
| Gross Margin | +45.70% |
| Operating Margin | +16.11% |
| Profit Margin | +8.38% |
| ROE | +26.24% |
| Debt / Equity | 213.01 |
| Current Ratio | 0.83 |
| Total Cash | $6.13B |
| Total Debt | $62.85B |
| Free Cash Flow | $4.37B |
Source: Nexqual, July 25, 2026 at 03:03 UTC.
Financial Health Score (NSRGF)
Nexqual rates NSRGF's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:03 UTC.
| Growth | Weak — Revenue -2% YoY (annual), declining |
|---|---|
| Profitability | Strong — Gross margin 46%, operating 16% |
| Balance Sheet | Critical — $6.13B cash vs $62.8B debt |
| Cash Flow | Mixed — FCF $4.37B, slim 4.9% margin |
| Efficiency | Strong — ROE 26%, ROA 6.6% |
Ownership (NSRGF)
| Insider Ownership | +0.02% |
|---|---|
| Institutional Ownership | +47.21% |
| Shares Outstanding | 2.57B |
| Float | 2.57B |
Source: Nexqual, July 25, 2026 at 03:03 UTC.
Leadership (NSRGF)
NSRGF is led by Philipp Navratil (age 49), CEO & Member of the Executive Board, per Nexqual as of July 25, 2026 at 03:03 UTC.
| CEO & Member of the Executive Board | Philipp Navratil (age 49) |
|---|---|
| Executive VP, CFO & Member of Executive Board | Anna Olive Magdelene Manz (age 52) |
| Executive VP, CTO & Member of Executive Board | Stefan Palzer (age 56) |
Major Backers & Investors (NSRGF)
Notable institutional backers of NSRGF include Goldman Sachs, AMERICAN BALANCED FUND, Fidelity, according to Nexqual as of July 25, 2026 at 03:03 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Goldman Sachs | 0.65% |
| AMERICAN BALANCED FUND | 0.42% |
| Fidelity | 0.38% |
| AMERICAN FUNDS FUNDAMENTAL INVESTORS | 0.37% |
| Income Fund of America | 0.36% |
| Capital Group | 0.36% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.43% |
| BlackRock | 1.09% |
Source: Nexqual, July 25, 2026 at 03:03 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NVSEF | Novartis AG | USD 154.47 | ▲ 0.95% |
| RHHVF | Roche Holding Ltd | USD 437 | ▲ 7.38% |
| LRLCF | L'Oreal Co. | USD 415 | ▼ 3.62% |
| RHHBF | Roche Holding Ltd | USD 430 | ▲ 1.13% |
| NONOF | Novo-Nordisk A/S | USD 49.25 | ▲ 1.57% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:03 UTC. This page is informational and not investment advice.